Consequently, protein expression levels of PI3K, AKT, MMP2, and MMP9 that are the proteins implicated in cancer progression in the siRNA-treated group were significantly decreased, stipulating that the cancer-promoting effect of MLLT11 might be related to the PI3K/AKT signaling pathway. Here, AKT1 is linked to cancer.